TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean Daily Frequency of Moderate and Severe Hot Flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Severity of Moderate and Severe Hot Flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants receiving Anti-osteoporosis Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Success of Pulpal Anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of comorbid spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of discontinuation of study medication due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Average Scores for VLS Clinical Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Scores for VLS Architectural Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease control rate at 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Progression-free Survival (PFS) at Six Months
Endpoint domain: Mortality/survival
Primary endpoint: Mean daily BG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of MRTX849 and TNO155
Endpoint domain: Adverse events/effects
Primary endpoint: Baseline and postprandial blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ad libitum lunch intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate-Specific Antigen (PSA) response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total opioid use 24 hours after cesarean delivery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total opioid use at time of hospital discharge after cesarean delivery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VAS (Visual Analog Score) pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Scale (VAS) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRKP occurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Time to wound bed healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of infection after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of solicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Ad4 seroconversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ad7 seroconversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: chemical pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: the clinical pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: The ongoing pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Long term safety of GNbAC1
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Serious Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of operations under general anaesthesia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of operations under local anaesthesia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients in whom breast surgery is performed ≤21 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concordance of IONA test results with invasive test or birth outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in CDRS-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving HBsAg Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 7-day all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Heavy Drinking Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Serum Concentration-Time Curve (AUC) of Ocrelizumab following subcutaneous (SC) administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with change from baseline in Marked Abnormality in Electrocardiogram (ECG) Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Achieved a Major Clinical Response (MCR), Partial Clinical Response (PCR), or Nonclinical Response (NCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of moderate or severe exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: New York Heart Association (NYHA) Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Six(6)-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in LDL tendency to oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of patients with sustained response after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients Attaining Adequate Azithromycin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime Ambulatory Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of composite HIV/STIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: rates of sexual risk behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: CSF markers related to dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stroke Rehabilitation Assessment of Movement (STREAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function test (PFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baseline Dyspnea Index (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-Care Management Scale in Chronic Diseases (SCMP-G)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of adherence to screening colonoscopy referral
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Evidence of atrial physiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in regional blood flow and perfusion characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in Central Volume Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in distance from periodontal pocket to cementoenamel junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postmenstrual age at full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Traumatic Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cystic Fibrosis Questionnaire-Revised respiratory component (CFQ-R) respiratory symptom score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to create sleeve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percent of staple firings with technical difficulties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to load staple cartridges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Glucose change in response to OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin change in response to OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of children <5 years with severe febrile illness resulting in death within 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of increase of iris pigmentation
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of development in darkening/lengthening/thickening of eyelashes and/or pigmentation of periorbital skin
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of ocular/periorbital adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants readmitted due to biliary pathology
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Discontinuing Due to Symptom Worsening
Endpoint domain: Adverse events/effects
Primary endpoint: Linear distance between planned and real implant apex position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Angle between the planned and real implant axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ablation Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: D&E Procedure Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite Event of Stroke/Non-CNS Systemic Embolism
Endpoint domain: Mortality/survival
Primary endpoint: Composite Event of Major/Non-major Clinically Relevant Bleeding Events
Endpoint domain: Adverse events/effects
Primary endpoint: Hospital Admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Overall satisfaction with treatments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional impact of treatments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: %PECmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %PEAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVF performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Apnea Diagnosis Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertension Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First attempt successful rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Second attempt successful rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall successful rate insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of induction of abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to biochemical recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Durable hematopoietic engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Test result QST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Result SF 36 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 10 meter walk test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of the Arm, Shoulder and Hand Score (QuickDash)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in disease burden using RECIST 1.1 or Lugano criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients having a benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: B Memory Cell Response (% of Memory B Cells That Are Antigen-specific)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasmablast Response (% of All B Cells That Are Plasmablasts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in doctors' practices for managing emergency care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of colony forming units (CFU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: OAB symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urodynamic variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval between surgical interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tissue levels of PGF2α
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Plasma LDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall Survival (OS) in All Participants
Endpoint domain: Mortality/survival
Primary endpoint: Overall Survival (OS) in Participants With PD-L1 CPS≥1
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Adverse Events and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Annualized Bleeding Rate for Treated Bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of adverse events of special interest (AESIs) considered related to study vaccination overall
Endpoint domain: Adverse events/effects
Primary endpoint: Number of related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with new onset of a chronic medical condition overall
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Schistocytes Per 1,000 Red Blood Cells (RBCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PTSD symptoms severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of AZD6140 and AR-C124910XX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Preclinical Alzheimer Cognitive Composite 5 (PACC5) Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Amyloid Positron Emission Tomography (PET) Standard Uptake Value Ratio (SUVr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of circulating tumour cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Disease Severity Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum number of follicles >= 5 mm (nmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dose-normalized maximum plasma concentration (Cmax) post single dose Org 36286
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with an adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter site inspection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of adverse/serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Parental Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete reversal of hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mental capacity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time with blood glucose >140 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BrainHQ Learning Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of inducing therapeutic seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to Give CPR
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Serum LDL cholesterol concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oral mucositis scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of MBSR program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Maximal plasma cortisol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Child psychological attributes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall safety of PRTX-100
Endpoint domain: Adverse events/effects
Primary endpoint: Plasminogen Activator Inhibitor 1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-versus-time Curve (AUC) 0 to Infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Apparent Terminal Elimination Half-life (t1/2el)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Minutes Per Day of Physical Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Conversion to open thoracotomy
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: mean change in insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean change in Glasgow Prognostic Score (GPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in serum level of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall Response Rate Based on the Hematologic Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Renal Function (GFR, creatinine clearance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ctDNA measurement predicting treatment outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ventilator days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in corneal confocal microscopic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in markers of autophagy in prostate tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of markers of autophagy in prostate tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of aminotransferases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain response improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of core temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change From Baseline on Psychological Distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of metachronous colorectal adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Rhinitis Control Assessment Test (RCAT) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of propofol and oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibitor Development
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma concentrations of PF 03382792 and its N dealkylated metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autonomic nervous system activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to Complete Remission of Lesions
Endpoint domain: Mortality/survival
Primary endpoint: Duration of Complete Remission (DOR)
Endpoint domain: Mortality/survival
Primary endpoint: Tolerability assessed by dose compliance
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with WHO grade 3 and grade 4 toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: resuscitation failure
Endpoint domain: Mortality/survival
Primary endpoint: area under curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of discordant lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in HBCS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in MARS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status